Avisa Diagnostics Stock Analysis
Avisa Diagnostics' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Avisa Diagnostics' financial risk is the risk to Avisa Diagnostics stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Avisa Diagnostics' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Avisa Diagnostics is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Avisa Diagnostics to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Avisa Diagnostics is said to be less leveraged. If creditors hold a majority of Avisa Diagnostics' assets, the Company is said to be highly leveraged.
Avisa Diagnostics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Avisa Diagnostics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Avisa Diagnostics is worth, separate from its market price. There are two main types of Avisa Diagnostics' stock analysis: fundamental analysis and technical analysis.
The Avisa Diagnostics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Avisa Diagnostics' ongoing operational relationships across important fundamental and technical indicators.
Avisa |
Avisa Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. Avisa Diagnostics last dividend was issued on the 12th of August 2016. The entity had 1:15 split on the 18th of May 2021. Avisa Diagnostics Inc. operates a clinical-stage medical device company. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics is traded on OTC Exchange in the United States.The quote for Avisa Diagnostics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Avisa Diagnostics call David Joseph at 505 820 1400 or check out https://www.avisadx.com.Avisa Diagnostics Investment Alerts
| Avisa Diagnostics generated a negative expected return over the last 90 days | |
| Avisa Diagnostics has some characteristics of a very speculative penny stock | |
| Avisa Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Avisa Diagnostics has accumulated 153.44 K in total debt. Avisa Diagnostics has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Avisa Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Avisa Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avisa Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avisa to invest in growth at high rates of return. When we think about Avisa Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 277.83 K. Net Loss for the year was (715.76 K) with profit before overhead, payroll, taxes, and interest of 129.28 K. | |
| Avisa Diagnostics has accumulated about 97.6 K in cash with (452.28 K) of positive cash flow from operations. |
Avisa Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 988. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avisa Diagnostics's market, we take the total number of its shares issued and multiply it by Avisa Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Avisa Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Avisa Diagnostics Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Avisa Diagnostics price series with the more recent values given greater weights.
Avisa Diagnostics Debt to Cash Allocation
Many companies such as Avisa Diagnostics, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Avisa Diagnostics has accumulated 153.44 K in total debt. Avisa Diagnostics has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Avisa Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Avisa Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avisa Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avisa to invest in growth at high rates of return. When we think about Avisa Diagnostics' use of debt, we should always consider it together with cash and equity.Avisa Diagnostics Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Avisa Diagnostics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Avisa Diagnostics, which in turn will lower the firm's financial flexibility.About Avisa Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Avisa Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avisa shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Avisa Diagnostics. By using and applying Avisa Pink Sheet analysis, traders can create a robust methodology for identifying Avisa entry and exit points for their positions.
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Avisa Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Complementary Tools for Avisa Pink Sheet analysis
When running Avisa Diagnostics' price analysis, check to measure Avisa Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avisa Diagnostics is operating at the current time. Most of Avisa Diagnostics' value examination focuses on studying past and present price action to predict the probability of Avisa Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avisa Diagnostics' price. Additionally, you may evaluate how the addition of Avisa Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |